oxidopamine has been researched along with Brain Disorders in 61 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The work shows the effects of caffeine after the intrastriatal injection of 6-OHDA in rats, considered as a model of Parkinson disease (PD)." | 3.73 | Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats. ( Aguiar, LM; Cunha, GM; Freitas, RM; Macêdo, DS; Nobre, HV; Oliveira, AA; Sousa, FC; Vasconcelos, SM; Viana, GS, 2006) |
| " Interestingly, firing rates of neurons in all groups decreased by fivefold or greater under urethane anesthesia, although the relative firing rates between hemispheres were unchanged." | 3.70 | Multiple single-unit recordings in the striatum of freely moving animals: effects of apomorphine and D-amphetamine in normal and unilateral 6-hydroxydopamine-lesioned rats. ( Gerhardt, GA; Kish, LJ; Palmer, MR, 1999) |
| "Levodopa, the major treatment for patients with Parkinson's disease, has been shown to induce a variety of compensatory effects, including facilitation of sprouting by dopaminergic neurons, in experimental animals with lesions leading to denervation of the striatum." | 1.32 | Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system. ( Delfino, MA; Ferrario, JE; Gershanik, O; Mourlevat, S; Murer, MG; Raisman-Vozari, R; Ruberg, M; Stefano, A; Taravini, IR, 2004) |
| "Pergolide was more potent than bromocriptine or lergotrile." | 1.26 | Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway. ( Duvoisin, RC; Heikkila, RE; Manzino, L, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (40.98) | 18.7374 |
| 1990's | 19 (31.15) | 18.2507 |
| 2000's | 15 (24.59) | 29.6817 |
| 2010's | 2 (3.28) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, X | 1 |
| Yuan, W | 1 |
| Li, Z | 1 |
| Feng, J | 1 |
| Li, X | 1 |
| Chen, Z | 1 |
| Tang, J | 1 |
| Liu, C | 1 |
| Zou, P | 1 |
| Huang, H | 1 |
| Tan, C | 1 |
| Yu, H | 1 |
| Androutsellis-Theotokis, A | 1 |
| Rueger, MA | 1 |
| Mkhikian, H | 1 |
| Korb, E | 1 |
| McKay, RD | 1 |
| Jaworski, RL | 1 |
| Blair, ML | 1 |
| Moroz, IA | 1 |
| Peciña, S | 1 |
| Schallert, T | 1 |
| Stewart, J | 1 |
| Ferrario, JE | 1 |
| Taravini, IR | 1 |
| Mourlevat, S | 1 |
| Stefano, A | 1 |
| Delfino, MA | 1 |
| Raisman-Vozari, R | 1 |
| Murer, MG | 1 |
| Ruberg, M | 1 |
| Gershanik, O | 1 |
| Kim, MS | 1 |
| Lee, JI | 1 |
| Lee, WY | 1 |
| Kim, SE | 1 |
| Grothe, C | 1 |
| Timmer, M | 1 |
| Scholz, T | 1 |
| Winkler, C | 1 |
| Nikkhah, G | 1 |
| Claus, P | 1 |
| Itoh, N | 1 |
| Arenas, E | 2 |
| Courtière, A | 1 |
| Hardouin, J | 1 |
| Locatelli, V | 1 |
| Turle-Lorenzo, N | 1 |
| Amalric, M | 2 |
| Vidal, F | 1 |
| Hasbroucq, T | 1 |
| Aguiar, LM | 1 |
| Nobre, HV | 1 |
| Macêdo, DS | 1 |
| Oliveira, AA | 1 |
| Freitas, RM | 1 |
| Vasconcelos, SM | 1 |
| Cunha, GM | 1 |
| Sousa, FC | 1 |
| Viana, GS | 1 |
| Parish, CL | 1 |
| Beljajeva, A | 1 |
| Simon, A | 1 |
| Nakai, K | 1 |
| Kasamatsu, T | 1 |
| Duvoisin, RC | 1 |
| Heikkila, RE | 1 |
| Manzino, L | 1 |
| Pritzel, M | 1 |
| Huston, JP | 2 |
| Sarter, M | 1 |
| Kojima, H | 1 |
| Gorio, A | 1 |
| Janigro, D | 1 |
| Jonsson, G | 1 |
| Sumners, C | 1 |
| Woodruff, GN | 1 |
| Poat, JA | 1 |
| Hossain, MA | 2 |
| Weiner, N | 2 |
| Pei, G | 1 |
| Ebendal, T | 1 |
| Boldry, RC | 1 |
| Chase, TN | 1 |
| Engber, TM | 1 |
| Schwarting, RK | 1 |
| Goldenberg, R | 1 |
| Steiner, H | 1 |
| Fornaguera, J | 1 |
| Annett, LE | 1 |
| Martel, FL | 1 |
| Rogers, DC | 1 |
| Ridley, RM | 1 |
| Baker, HF | 1 |
| Dunnett, SB | 2 |
| Kondoh, T | 1 |
| Low, WC | 2 |
| Sørensen, JC | 1 |
| Ostergaard, K | 1 |
| Zimmer, J | 1 |
| Zhu, YS | 1 |
| Jones, SB | 1 |
| Burke, RE | 1 |
| Franklin, SO | 1 |
| Inturrisi, CE | 1 |
| Poncelet, M | 1 |
| Gueudet, C | 1 |
| Gully, D | 1 |
| Soubrié, P | 1 |
| Le Fur, G | 1 |
| Ouagazzal, A | 1 |
| Nieoullon, A | 2 |
| Efange, SM | 1 |
| Langason, RB | 1 |
| Khare, AB | 1 |
| Fenu, S | 1 |
| Pinna, A | 1 |
| Ongini, E | 1 |
| Morelli, M | 1 |
| Araki, T | 1 |
| Tanji, H | 1 |
| Kato, H | 1 |
| Itoyama, Y | 1 |
| Kish, LJ | 1 |
| Palmer, MR | 1 |
| Gerhardt, GA | 1 |
| Laprade, N | 1 |
| Soghomonian, JJ | 1 |
| Joseph, MH | 1 |
| Peters, SL | 1 |
| Moran, PM | 1 |
| Grigoryan, GA | 1 |
| Young, AM | 1 |
| Gray, JA | 1 |
| Ni, ZG | 1 |
| Gao, DM | 1 |
| Benabid, AL | 1 |
| Benazzouz, A | 1 |
| Vaudano, E | 1 |
| Rosenblad, C | 1 |
| Björklund, A | 3 |
| Xia, XG | 1 |
| Schmidt, N | 1 |
| Teismann, P | 1 |
| Ferger, B | 1 |
| Schulz, JB | 1 |
| Zahran, AR | 1 |
| Simmerman, N | 1 |
| Carrier, S | 1 |
| Vachon, P | 1 |
| Asanuma, M | 1 |
| Miyazaki, I | 1 |
| Higashi, Y | 1 |
| Tanaka, K | 1 |
| Haque, ME | 1 |
| Fujita, N | 1 |
| Ogawa, N | 1 |
| Castañeda, E | 1 |
| Whishaw, IQ | 2 |
| Robinson, TE | 1 |
| Ozaki, A | 1 |
| Ikegami, A | 1 |
| Yoshidomi, M | 1 |
| Yamashita, A | 1 |
| Sukamoto, T | 1 |
| Meloni, R | 1 |
| Gale, K | 1 |
| Levin, BE | 1 |
| Battisti, WP | 1 |
| Murray, M | 1 |
| Mahalik, TJ | 1 |
| Finger, TE | 1 |
| Stromberg, I | 1 |
| Olson, L | 1 |
| Jones, GH | 1 |
| Isacson, O | 2 |
| Apicella, P | 1 |
| Legallet, E | 1 |
| Trouche, E | 1 |
| Hyttel, J | 1 |
| Arnt, J | 1 |
| Gerfen, CR | 1 |
| Baimbridge, KG | 1 |
| Thibault, J | 1 |
| Jenner, P | 1 |
| Boyce, S | 1 |
| Marsden, CD | 1 |
| Robain, O | 1 |
| Lanfumey, L | 1 |
| Adrien, J | 1 |
| Farkas, E | 1 |
| Nishino, H | 2 |
| Ono, T | 2 |
| Takahashi, J | 2 |
| Kimura, M | 2 |
| Shiosaka, S | 2 |
| Yamasaki, H | 1 |
| Hatanaka, H | 1 |
| Tohyama, M | 2 |
| Orr, WB | 1 |
| Gardiner, TW | 1 |
| Stricker, EM | 2 |
| Zigmond, MJ | 2 |
| Berger, TW | 2 |
| Nisenbaum, ES | 1 |
| Choulli, K | 1 |
| Herman, JP | 1 |
| Rivet, JM | 1 |
| Simon, H | 1 |
| Le Moal, M | 1 |
| Fibiger, HC | 1 |
| LePiane, FG | 1 |
| Jakubovic, A | 1 |
| Phillips, AG | 1 |
| Gramsbergen, JB | 1 |
| Veenma-van der Duin, L | 1 |
| Loopuijt, L | 1 |
| Paans, AM | 1 |
| Vaalburg, W | 1 |
| Korf, J | 1 |
| Lindvall, O | 1 |
| Auer, RN | 1 |
| Siesjö, BK | 1 |
| Shimizu, K | 1 |
| Tsuda, N | 1 |
| Okamoto, Y | 1 |
| Matsui, Y | 1 |
| Miyao, Y | 1 |
| Tamura, K | 1 |
| Yamada, M | 1 |
| Nakatani, S | 1 |
| Ikeda, T | 1 |
| Mogami, H | 1 |
| Brundin, P | 1 |
| Barbin, G | 1 |
| Mallat, M | 1 |
| Chamak, B | 1 |
| Prochiantz, A | 1 |
| Gage, FH | 2 |
| Pellis, SM | 1 |
| Chen, YC | 1 |
| Chesire, RM | 1 |
| Teitelbaum, P | 1 |
3 reviews available for oxidopamine and Brain Disorders
| Article | Year |
|---|---|
Signaling pathways controlling neural stem cells slow progressive brain disease.
Topics: Adult; Animals; Basic Helix-Loop-Helix Transcription Factors; Brain Diseases; Cell Survival; Dopamin | 2008 |
Receptor changes during chronic dopaminergic stimulation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocripti | 1988 |
Neural grafting in animal models of neurodegenerative diseases.
Topics: Aging; Animals; Behavior, Animal; Brain; Brain Diseases; Choline; Corpus Striatum; Denervation; Dise | 1985 |
58 other studies available for oxidopamine and Brain Disorders
| Article | Year |
|---|---|
An autophagic mechanism is involved in the 6-hydroxydopamine-induced neurotoxicity in vivo.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Behavior, Animal; Brain Diseases; Gene Expression | 2017 |
Synthesis and biological evaluation of 10-(11) C-dihydrotetrabenazine as a vesicular monoamine transporter 2 radioligand.
Topics: Animals; Brain Diseases; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Molecular Structure; Oxi | 2014 |
Lesions of the dorsal noradrenergic bundle augment the renin response to blood loss but do not alter hypothalamic Fos expression.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Blood Pressure; Brain Diseases; Cell Count; Heart | 2004 |
Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Behav | 2004 |
Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Brain Diseases; Calmodulin; Carrier Proteins; Cell | 2004 |
Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson's disease.
Topics: Animals; Brain Diseases; Disease Models, Animal; Gait; Ginkgo biloba; Male; Neuroprotective Agents; | 2004 |
Fibroblast growth factor-20 promotes the differentiation of Nurr1-overexpressing neural stem cells into tyrosine hydroxylase-positive neurons.
Topics: Animals; Brain Diseases; Cell Differentiation; Cell Line; Corpus Striatum; DNA-Binding Proteins; Dop | 2004 |
Selective effects of partial striatal 6-OHDA lesions on information processing in the rat.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Brain Chemistry; Brain Diseases; Brain Injuries; Choic | 2005 |
Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats.
Topics: Animals; Apomorphine; Brain; Brain Diseases; Caffeine; Disease Models, Animal; Dopamine Agents; Male | 2006 |
Midbrain dopaminergic neurogenesis and behavioural recovery in a salamander lesion-induced regeneration model.
Topics: Animals; Behavior, Animal; Brain Diseases; Cell Differentiation; Dopamine; Mesencephalon; Models, An | 2007 |
Accelerated regeneration of central catecholamine fibers in cat occipital cortex: effects of substance P.
Topics: Animals; Bethanechol; Bethanechol Compounds; Brain Diseases; Cats; Histocytochemistry; Hydroxydopami | 1984 |
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
Topics: Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Ergolines; Female; Hydroxydopamines; Oxido | 1982 |
Behavioral and neuronal reorganization after unilateral substantia nigra lesions: evidence for increased interhemispheric nigrostriatal projections.
Topics: Animals; Behavior, Animal; Brain Diseases; Brain Mapping; Catecholamines; Corpus Striatum; Hydroxydo | 1983 |
GM1 ganglioside enhances regrowth of noradrenaline nerve terminals in rat cerebral cortex lesioned by the neurotoxin 6-hydroxydopamine.
Topics: Adrenergic Fibers; Animals; Brain Diseases; Cerebral Cortex; G(M1) Ganglioside; Gangliosides; Hydrox | 1984 |
Effects of specific dopamine lesions and dopamine receptor sensitivity on angiotensin II- and carbachol-induced thirst in rats.
Topics: Angiotensin II; Animals; Brain Diseases; Carbachol; Corpus Striatum; Dopamine; Haloperidol; Hydroxyd | 1981 |
Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Topics: Animals; Brain Diseases; Corpus Striatum; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagoni | 1995 |
Specific lesions in the extrapyramidal system of the rat brain induced by 3-nitropropionic acid (3-NPA).
Topics: Animals; Base Sequence; Behavior, Animal; Brain Diseases; Corpus Striatum; Dopamine; Female; Male; M | 1995 |
Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Brain Disease | 1993 |
A video image analyzing system for open-field behavior in the rat focusing on behavioral asymmetries.
Topics: Animals; Behavior, Animal; Brain Diseases; Computers; Dopamine Agents; Image Processing, Computer-As | 1993 |
Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway.
Topics: Animals; Behavior, Animal; Brain Diseases; Brain Tissue Transplantation; Callithrix; Caudate Nucleus | 1994 |
Glutamate uptake blockade induces striatal dopamine release in 6-hydroxydopamine rats with intrastriatal grafts: evidence for host modulation of transplanted dopamine neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Diseases; Brain Tissue Transplantation; Corpus | 1994 |
Grafting of dopaminergic ventral mesencephalic slice cultures to the striatum of adult rats.
Topics: Animals; Animals, Newborn; Brain Diseases; Brain Tissue Transplantation; Corpus Striatum; Culture Te | 1994 |
Quantitation of the levels of tyrosine hydroxylase and preproenkephalin mRNAs in nigrostriatal sites after 6-hydroxydopamine lesions.
Topics: Animals; Apomorphine; Brain Diseases; Corpus Striatum; Dopamine; Enkephalins; Gene Expression; Male; | 1993 |
Turning behavior induced by intrastriatal injection of neurotensin in mice: sensitivity to non-peptide neurotensin antagonists.
Topics: Animals; Behavior, Animal; Brain Diseases; Corpus Striatum; Dopamine; Dose-Response Relationship, Dr | 1994 |
Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
Topics: Amphetamine; Animals; Brain; Brain Diseases; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamin | 1994 |
Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biopterins; Brain Diseases; Carbidopa; Corpus Striatum; Cyc | 1993 |
The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson'
Topics: Animals; Brain Diseases; Cholinergic Fibers; Corpus Striatum; Disease Models, Animal; Dopamine Antag | 1996 |
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Behavior, Animal; Brain Diseases; Dopamine Agonists; Drug Synergism; Gene Expression; Genes | 1997 |
Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
Topics: Adrenergic Agents; Animals; Autoradiography; Benzamides; Benzazepines; Brain Diseases; Dopamine; Dop | 1998 |
Multiple single-unit recordings in the striatum of freely moving animals: effects of apomorphine and D-amphetamine in normal and unilateral 6-hydroxydopamine-lesioned rats.
Topics: Anesthesia; Anesthetics, Intravenous; Animals; Apomorphine; Brain Diseases; Corpus Striatum; Dextroa | 1999 |
Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differentially altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates.
Topics: Animals; Animals, Newborn; Brain Diseases; Corpus Striatum; Dynorphins; Enkephalins; Gene Expression | 1999 |
Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning.
Topics: Amphetamine; Animals; Association Learning; Behavior, Animal; Brain Diseases; Conditioning, Psycholo | 2000 |
Unilateral lesion of the nigrostriatal pathway induces a transient decrease of firing rate with no change in the firing pattern of neurons of the parafascicular nucleus in the rat.
Topics: Action Potentials; Animals; Brain Diseases; Corpus Striatum; Electrophysiology; Immunohistochemistry | 2000 |
Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor.
Topics: Aging; Animals; Animals, Newborn; Brain Diseases; Cell Death; Dopamine; Female; Glial Cell Line-Deri | 2001 |
Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Benzazepines; Brain Diseases; Carbido | 2001 |
Erectile dysfunction occurs following substantia nigra lesions in the rat.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Diseases; Corpus Striatum; Dopamine; Dopamine Agonists | 2001 |
Aggravation of 6-hydroxydopamine-induced dopaminergic lesions in metallothionein-I and -II knock-out mouse brain.
Topics: Animals; Brain; Brain Diseases; Denervation; Dopamine Plasma Membrane Transport Proteins; Injections | 2002 |
Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Brain Diseases; Corpus Striatum; Dialysis; Dop | 1990 |
Behavioral and biochemical effects of a novel calcium antagonist, KB-2796, on the central dopaminergic system.
Topics: Animals; Apomorphine; Behavior, Animal; Biogenic Monoamines; Brain; Brain Diseases; Calcium Channel | 1991 |
Cocaine-induced turning behavior in rats with 6-hydroxydopamine lesions: effect of transplants of fetal substantia nigra.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain Diseases; Brain Tissue Transplantation; C | 1991 |
Axonal transport of beta-receptors during the response to axonal injury and repair in locus coeruleus neurons.
Topics: Animals; Axonal Transport; Brain Diseases; Catecholamines; Hydroxydopamines; Locus Coeruleus; Male; | 1985 |
Substantia nigra transplants into denervated striatum of the rat: ultrastructure of graft and host interconnections.
Topics: Animals; Brain Diseases; Corpus Striatum; Hydroxydopamines; Microscopy, Electron; Oxidopamine; Rats; | 1985 |
Effects of dopamine-rich grafts on conditioned rotation in rats with unilateral 6-hydroxydopamine lesions.
Topics: Animals; Behavior, Animal; Brain; Brain Diseases; Conditioning, Psychological; Corpus Striatum; Dopa | 1986 |
Differential time-course of reaction time recovery depending on variations in the amplitude of a goal-directed movement after nigrostriatal lesion in monkeys.
Topics: Animals; Brain Diseases; Caudate Nucleus; Corpus Striatum; Dopamine; Hydroxydopamines; Motor Activit | 1986 |
Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.
Topics: Animals; Antipsychotic Agents; Benzazepines; Brain; Brain Diseases; Hydroxydopamines; Male; Oxidopam | 1987 |
The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems.
Topics: Animals; Brain Diseases; Calbindins; Corpus Striatum; Dopamine; Hydroxydopamines; Mesencephalon; Neu | 1987 |
Developmental changes in the cerebellar cortex after locus ceruleus lesion with 6-hydroxydopamine in the rat.
Topics: Animals; Brain Diseases; Cerebellum; Cerebral Cortex; Hydroxydopamines; Locus Coeruleus; Oxidopamine | 1985 |
The formation of new neuronal circuit between transplanted nigral dopamine neurons and non-immunoreactive axon terminals in the host rat caudate nucleus.
Topics: Animals; Brain Diseases; Dopamine; Female; Graft Survival; Hydroxydopamines; Microscopy, Electron; M | 1986 |
Transplants in the peri- and intraventricular region grow better than those in the central parenchyma of the caudate.
Topics: Animals; Brain Diseases; Corpus Striatum; Dopamine; Hydroxydopamines; Mesencephalon; Methamphetamine | 1986 |
Short-term effects of dopamine-depleting brain lesions on spontaneous activity of striatal neurons: relation to local dopamine concentration and behavior.
Topics: Animals; Behavior, Animal; Brain Diseases; Corpus Striatum; Dopamine; Hydroxydopamines; Injections, | 1986 |
Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: relation to behavioral recovery.
Topics: Action Potentials; Animals; Brain Diseases; Corpus Striatum; Dopamine; Haloperidol; Hydroxydopamines | 1986 |
Spontaneous and graft-induced behavioral recovery after 6-hydroxydopamine lesion of the nucleus accumbens in the rat.
Topics: Animals; Brain Diseases; Corpus Striatum; Dopamine; Female; Hydroxydopamines; Mesencephalon; Nucleus | 1987 |
The role of dopamine in intracranial self-stimulation of the ventral tegmental area.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Corpus Striatum; Dopamine; Electric Stimula | 1987 |
Imaging of the degeneration of neurons and their processes in rat or cat brain by 45CaCl2 autoradiography or 55CoCl2 positron emission tomography.
Topics: Animals; Autoradiography; Brain; Brain Diseases; Calcium; Calcium Chloride; Calcium Radioisotopes; C | 1988 |
Mechanisms of hypoglycemic brain damage. Evidence against a significant role of the noradrenergic locus coeruleus system.
Topics: Animals; Brain Diseases; Hydroxydopamines; Hypoglycemia; Locus Coeruleus; Male; Norepinephrine; Oxid | 1988 |
Transplant-induced recovery from 6-OHDA lesions of the nigrostriatal dopamineneurones in mice.
Topics: Animals; Brain Diseases; Corpus Striatum; Dopamine; Female; Hydroxydopamines; Mice; Mice, Inbred C3H | 1988 |
Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro.
Topics: Animals; Brain Diseases; Cells, Cultured; Corpus Striatum; Dopamine; Female; Fetus; Hydroxydopamines | 1985 |
Head displacement and bracing in haloperidol-treated rats compared to rats with lateral hypothalamic damage.
Topics: Animals; Brain Diseases; Catalepsy; Disease Models, Animal; Haloperidol; Hydroxydopamines; Hypothala | 1985 |